Abstract:Background/Objectives Pregnant women are exposed to numerous endocrine disrupting chemicals (EDCs) that can affect hormonal pathways regulating pregnancy outcomes and fetal development. Thus, we evaluated overall and fetal sex-specific associations of phthalate/replacement, paraben, and phenol biomarkers with sex-steroid and thyroid hormones. Methods Illinois women (n=302) provided plasma for progesterone, estradiol, testosterone, free T4 (FT4), total T4 (TT4), and thyroid stimulating hormone (TSH) at median 17 weeks gestation. Women also provided up-to-five first-morning urine samples monthly across pregnancy (8-40 weeks), which we pooled to measure 19 phthalate/replacement metabolites (reflecting ten parent compounds), three parabens, and six phenols. We used linear regression to evaluate overall and fetal sex-specific associations of biomarkers with hormones, as well as weighted quantile sum and Bayesian kernel machine regression (BKMR) to assess cumulative associations, non-linearities, and chemical interactions. Results In women of relatively high socioeconomic status, several EDC biomarkers were associated with select hormones, without cumulative or non-linear associations with progesterone, FT4, or TT4. The biomarker mixture was negatively associated with estradiol (only at higher biomarker concentrations using BKMR), testosterone, and TSH, where each 10% mixture increase was associated with -5.65% (95%C.I.: -9.79, -1.28) lower testosterone and -0.09 μIU/mL (95%CI: -0.20, 0.00) lower TSH. Associations with progesterone, testosterone, and FT4 did not differ by fetal sex. However, in women carrying females, we identified an inverted u-shaped relationship of the mixture with estradiol. Additionally, in women carrying females, each 10% increase in the mixture was associated with 1.50% (95%CI: -0.15, 3.18) higher TT4, whereas in women carrying males, the mixture was associated with -1.77% (95%C.I.: -4.08, 0.58) lower TT4 and -0.18 μIU/mL (95%CI: -0.33, -0.03) lower TSH. We also identified select chemical interactions. Conclusion Some biomarkers were associated with early-to-mid pregnancy hormones. There were some sex-specific and non-linear associations. Future studies could consider how these findings relate to pregnancy/birth outcomes.

Urinary and air phthalate concentrations and self-reported use of personal care products among minority pregnant women in New York city

Factors Associated with Internal Phthalate Exposure among Pregnant Women

Exposure to phthalates from personal care products: Urinary levels and predictors of exposure

Personal care product use and urinary levels of phthalate metabolites in Mexican women

Associations of urinary di-(2-ethylhexyl) phthalate metabolites with the residential characteristics of pregnant women

Levels of Phthalate Metabolites in Urine of Pregnant Women and Risk of Clinical Pregnancy Loss

Association of Urinary Phthalate and Phthalate Replacement Metabolite Concentrations with Serum Lipid Biomarker Levels among Pregnant Women Attending a Fertility Center

Urinary concentrations of phthalate metabolites in relation to preeclampsia and other hypertensive disorders of pregnancy in the environmental influences on child health outcomes (ECHO) program

Personal care product use patterns in association with phthalate and replacement biomarkers across pregnancy

Personal care products use and phthalate exposure levels among pregnant women

Socio-Demographic Patterning of Urinary Mono-ethyl Phthalate Levels among Children and Adults in the U.S. (1999-2018)

Analyzing the impact of phthalate and DINCH exposure on fetal growth in a cohort with repeated urine collection

Dietary intake and household exposures as predictors of urinary concentrations of high molecular weight phthalates and bisphenol A in a cohort of adolescents

Phthalate exposure in association with the use of personal care products among general population from Shanghai

Urinary phthalate metabolite concentrations among workers in selected industries: a pilot biomonitoring study

Urinary phthalate metabolites in pregnant women: occurrences, related factors, and association with maternal hormones

Phthalate and DINCH urinary concentrations across pregnancy and risk of preterm birth

Associations of urinary non-persistent endocrine disrupting chemical biomarkers with early-to-mid pregnancy plasma sex-steroid and thyroid hormones

A Longitudinal Study of Urinary Phthalate Excretion in 58 Full-Term and 67 Preterm Infants from Birth through 14 Months

An insight into the chemical exposome during pregnancy - A non-targeted analysis study

Mixtures of Urinary Phenol and Phthalate Metabolite Concentrations in Relation to Serum Lipid Levels among Pregnant Women: Results from the EARTH Study